3-hydroxybutyric acid has been researched along with Heart Diseases in 3 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Severe ketoacidosis induces heart failure and cardiac arrest, but its mechanism is unknown." | 1.38 | Inhibitory effect of β-hydroxybutyric acid on L-type Ca(2+) current under β-adrenergic stimulation in guinea pig cardiac ventricular myocytes. ( Akama, Y; Kimura, J; Kurihara, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alfawara, MS | 2 |
| Ahmed, AI | 2 |
| Saad, JM | 2 |
| Han, Y | 2 |
| Alahdab, F | 2 |
| Al Rifai, M | 2 |
| Kassi, M | 2 |
| Alnabelsi, T | 2 |
| Zoghbi, WA | 2 |
| Al-Mallah, MH | 2 |
| Murano, C | 1 |
| Binda, A | 1 |
| Palestini, P | 1 |
| Baruscotti, M | 1 |
| DiFrancesco, JC | 1 |
| Rivolta, I | 1 |
| Kurihara, M | 1 |
| Akama, Y | 1 |
| Kimura, J | 1 |
1 review available for 3-hydroxybutyric acid and Heart Diseases
| Article | Year |
|---|---|
Effect of the ketogenic diet in excitable tissues.
Topics: 3-Hydroxybutyric Acid; Animals; Central Nervous System Diseases; Diet, Ketogenic; Energy Metabolism; | 2021 |
2 other studies available for 3-hydroxybutyric acid and Heart Diseases
| Article | Year |
|---|---|
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron | 2023 |
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron | 2023 |
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron | 2023 |
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron | 2023 |
Inhibitory effect of β-hydroxybutyric acid on L-type Ca(2+) current under β-adrenergic stimulation in guinea pig cardiac ventricular myocytes.
Topics: 3-Hydroxybutyric Acid; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; GTP-Binding Prot | 2012 |